Advertisement

Evolutionary determinants of polycystic ovary syndrome: part 2

      Polycystic ovary syndrome (PCOS) is a prehistoric complex genetic trait, perhaps dating back at least 50,000 years. The disorder also represents an evolutionary paradox, demonstrating clear reproductive disadvantages (i.e., lack of evolutionary fitness), albeit persisting tens of thousands of years. Here we examine possible explanations for this paradox. We evaluate a variety of possible benefits accruing to women in ancestral populations who possessed this trait, including considerations of whether dramatic changes in environment and lifestyle from the ancestral past to the contemporary present have altered the selection dynamics operating on the trait. Putative benefits include metabolic functioning, immune system dynamics, patterns of child-rearing and mothering, reproductive longevity, in utero or childhood survival, and musculoskeletal advantages. However, there is limited evidence that the persistence and relative homogeneity in the prevalence of PCOS can be accounted for by direct positive selection. Rather, PCOS evolution has likely been driven by nonadaptive evolutionary mechanisms, including genetic drift due to a serial founder effect and population balance due to sexually antagonistic selection. Ultimately, insights into the evolutionary origins of PCOS will emerge through the study not only of unique characteristics of affected individuals and their environments butalso through a broad consideration of the potential adaptive and beneficial aspects of vulnerability to the disorder, importantly including examination of populations whose fertility, disease load, and diet resemble those of ancestral humans.

      Key Words

      To read this article in full you will need to make a payment

      References

        • Lizneva D.
        • Suturina L.
        • Walker W.
        • Brakta S.
        • Gavrilova-Jordan L.
        • Azziz R.
        The criteria, prevalence and phenotypes of polycystic ovarian syndrome.
        Fertil Steril. 2016; 106: 6-15
        • Vink J.M.
        • Sadrzadeh S.
        • Lambalk C.B.
        • Boomsma D.I.
        Heritability of polycystic ovary syndrome in a Dutch twin-family study.
        J Clin Endocrinol Metab. 2006; 91: 2100-2104
        • Corbett S.
        • Morin-Papunen L.
        The polycystic ovary syndrome and recent human evolution.
        Mol Cell Endocrinol. 2013; 373: 39-50
        • Stein I.F.
        • Leventhal M.L.
        Amenorrhea associated with bilateral polycystic ovaries.
        Am J Obstet Gynecol. 1935; 29: 181-191
        • Azziz R.
        • Adashi E.Y.
        Stein and Leventhal: 80 years on.
        Am J Obstet Gynecol. 2016; 214: 247-256
      1. Hippocrates. Epidemics book VI, Aphorisms 55 and 56.
        in: Clifton Francis Hippocrates, upon air, water and situation; upon epidemical diseases; and upon prognosticks, in acute cases especially. J. Watts, London1734: 172
      2. Soranus of Ephesus, Temkin O. Book I, Art. 23 and Art. 29. In Temkin O, Eastman NJ, Edelstein L, Guttmacher AF. Soranus' Gynecology. Baltimore, MD: The Johns Hopkins University Press; 1991:19, 26.

        • Maimonedes M.
        Fin Liber Comm. Epidemirum VI, 8.
        in: The medical aphorism of Moses Maimonides, vol. 2. Yeshiva University Press, New York1971
        • Paré A.
        The causes of the suppression of the courses or menstrual fluxe.
        (Chap. LI, Lib. 24)in: Johnson T. trans The workes of that famous Chirurgion Ambrole Parey: Translated out of Latine and compared with the French. Th. Cotes and R. Young, London1634
        • Azziz R.
        PCOS in 2015: new insights into the genetics of polycystic ovary syndrome.
        Nat Rev Endocrinol. 2016; 12: 183
        • Tinbergen N.
        On aims and methods of ethology.
        Zeitschrift fur Tierpsychologie. 1963; 20: 410-433
        • Bateson P.
        • Laland K.N.
        Tinbergen's four questions: an appreciation and an update.
        Trends Ecol Evol. 2013; 28: 712-718
        • Holte J.
        Polycystic ovary syndrome and insulin resistance: thrifty genes struggling with over-feeding and sedentary life style?.
        J Endocrinol Invest. 1998; 21: 589-601
        • Escobar-Morreale H.F.
        • Luque-Ramirez M.
        • San Millan J.L.
        The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome.
        Endocr Rev. 2005; 26: 251-282
        • Gleicher N.
        • Barad D.
        An evolutionary concept of polycystic ovarian disease: does evolution favour reproductive success over survival?.
        Reprod Biomed Online. 2006; 12: 587-589
        • Shaw L.M.
        • Elton S.
        Polycystic ovary syndrome: a transgenerational evolutionary adaptation.
        Br J Obstet Gynecol. 2008; 115: 144-148
        • Speakman J.R.
        Evolutionary perspectives on the obesity epidemic: adaptive, maladaptive, and neutral viewpoints.
        Annu Rev Nutr. 2013; 33: 289-317
        • Corbett S.J.
        • McMichael A.J.
        • Prentice A.M.
        Type 2 diabetes, cardiovascular disease, and the evolutionary paradox of the polycystic ovary syndrome: a fertility first hypothesis.
        Am J Hum Biol. 2009; 21: 587-598
        • Vasunilashorn S.
        • Crimmins E.M.
        • Kim J.K.
        • Winking J.
        • Gurven M.
        • Kaplan H.
        • et al.
        Blood lipids, infection, and inflammatory markers in the Tsimane of Bolivia.
        Am J Hum Biol. 2010; 22: 731-740
        • Rook G.A.
        Review series on helminths, immune modulation and the hygiene hypothesis: the broader implications of the hygiene hypothesis.
        Immunology. 2009; 126: 3-11
        • Elliott D.E.
        • Summers R.W.
        • Weinstock J.V.
        Helminths as governors of immune-mediated inflammation.
        Int J Parasitol. 2007; 37: 457-464
        • Gurven M.
        • Kaplan H.
        • Winking J.
        • Eid Rodriguez D.
        • Vasunilashorn S.
        • Kim J.K.
        • et al.
        Inflammation and infection do not promote arterial aging and cardiovascular disease risk factors among lean horticulturalists.
        PLoS One. 2009; 4: e6590
        • Magen E.
        • Borkow G.
        • Bentwich Z.
        • Mishal J.
        • Scharf S.
        Can worms defend our hearts? Chronic helminthic infections may attenuate the development of cardiovascular diseases.
        Med Hypotheses. 2005; 64: 904-909
        • Eggers S.
        • Hashimoto D.M.
        • Kirchengast S.
        An evolutionary approach to explain the high frequency of the polycystic ovary syndrome (PCOS).
        Anthropol Anz. 2007; 65: 169-179
        • Casarini L.
        • Simoni M.
        • Brigante G.
        Is polycystic ovary syndrome a sexual conflict? A review.
        Reprod Biomed Online. 2016; 32: 350-361
        • Hawkes K.
        • Coxworth J.E.
        Grandmothers and the evolution of human longevity: a review of findings and future directions.
        Evol Anthropol. 2013; 22: 294-302
        • Croft D.P.
        • Brent L.J.
        • Franks D.W.
        • Cant M.A.
        The evolution of prolonged life after reproduction.
        Trends Ecol Evol. 2015; 30: 407-416
        • Azziz R.
        • Dumesic D.A.
        • Goodarzi M.O.
        Polycystic ovary syndrome: an ancient disorder?.
        Fertil Steril. 2011; 95: 1544-1548
        • Blurton Jones N.
        Bushman birth spacing: a test for optimal interbirth intervals.
        Ethol Sociobiol. 1986; 7: 91-105
        • Saxena R.
        • Bjonnes A.C.
        • Georgopoulos N.A.
        • Koika V.
        • Panidis D.
        • Welt C.K.
        Gene variants associated with age at menopause are also associated with polycystic ovary syndrome, gonadotrophins and ovarian volume.
        Hum Reprod. 2015; 30: 1697-1703
        • Perry J.R.
        • Hsu Y.H.
        • Chasman D.I.
        • Johnson A.D.
        • Elks C.
        • Albrecht E.
        • et al.
        DNA mismatch repair gene MSH6 implicated in determining age at natural menopause.
        Hum Mol Genet. 2014; 23: 2490-2497
        • Mulders A.G.
        • Laven J.S.
        • Eijkemans M.J.
        • de Jong F.H.
        • Themmen A.P.
        • Fauser B.C.
        Changes in anti-Müllerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility..
        Hum Reprod. 2004; 9: 2036-2042
        • Schmidt J.
        • Brännström M.
        • Landin-Wilhelmsen K.
        • Dahlgren E.
        Reproductive hormone levels and anthropometry in postmenopausal women with polycystic ovary syndrome (PCOS): a 21-year follow-up study of women diagnosed with PCOS around 50 years ago and their age-matched controls.
        J Clin Endocrinol Metab. 2011; 96: 2178-2185
        • Wild S.
        • Pierpoint T.
        • Jacobs H.
        • McKeigue P.
        Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study.
        Hum Fertil (Camb). 2000; 3: 101-105
        • Sterling L.
        • Liu J.
        • Okun N.
        • Sakhuja A.
        • Sierra S.
        • Greenblatt E.
        Pregnancy outcomes in women with polycystic ovary syndrome undergoing in vitro fertilization.
        Fertil Steril. 2016; 105: 791-797.e2
        • Fagny M.
        • Patin E.
        • Enard D.
        • Barreiro L.B.
        • Quintana-Murci L.
        • Laval G.
        Exploring the occurrence of classic selective sweeps in humans using whole-genome sequencing data sets.
        Mol Biol Evol. 2014; 31: 1850-1868
        • Kemper K.E.
        • Saxton S.J.
        • Bolormaa S.
        • Hayes B.J.
        • Goddard M.E.
        Selection for complex traits leaves little or no classic signatures of selection.
        BMC Genomics. 2014; 15: 246
        • Vallender E.J.
        • Lahn B.T.
        Positive selection on the human genome.
        Hum Mol Genet. 2004; 13 (Spec. No. 2: R245–54)
        • Casarini L.
        • Brigante G.
        The polycystic ovary syndrome evolutionary paradox: a genome-wide association studies-based, in silico, evolutionary explanation.
        J Clin Endocrinol Metab. 2014; 99: E2412-E2420
        • Legro R.S.
        • Kunselman A.R.
        • Demers L.
        • Wang S.C.
        • Bentley-Lewis R.
        • Dunaif A.
        Elevated dehydroepiandrosterone sulfate levels as the reproductive phenotype in the brothers of women with polycystic ovary syndrome.
        J Clin Endocrinol Metab. 2002; 87: 2134-2138